RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF
申请人:Beijing Tide Pharmaceutical Co., Ltd.
公开号:EP3770148A1
公开(公告)日:2021-01-27
The present invention discloses a receptor inhibitor of formula (I), a pharmaceutical composition comprising the same and the use thereof.
本发明公开了一种式(I)的受体抑制剂、由其组成的药物组合物及其用途。
Discovery of novel bacterial elongation condensing enzyme inhibitors by virtual screening
作者:Zhong Zheng、Joshua B. Parsons、Rajendra Tangallapally、Weixing Zhang、Charles O. Rock、Richard E. Lee
DOI:10.1016/j.bmcl.2014.03.033
日期:2014.6
The elongation condensing enzymes in the bacterial fatty acid biosynthesis pathway represent desirable targets for the design of novel, broad-spectrum antimicrobial agents. A series of substituted benzoxazolinones was identified in this study as a novel class of elongation condensing enzyme (FabB and FabF) inhibitors using a two-step virtual screening approach. Structure activity relationships were developed around the benzoxazolinone scaffold showing that N-substituted benzoxazolinones were most active. The benzoxazolinone scaffold has high chemical tractability making this chemotype suitable for further development of bacterial fatty acid synthesis inhibitors. (C) 2014 Elsevier Ltd. All rights reserved.
Design, Synthesis, and Biological Activity of Novel Triazole Sulfonamide Derivatives Containing a Benzylamine Moiety
these synthesized compounds. Most of these derivatives exhibited better fungicidal activities than that of the commercial cyanosole using bioassays. In particular, compounds 6g and 6h showed the best fungicidal activity against CDM (EC50 = 6.91 and 10.62 mg/L). Comparative experiments demonstrated that the fungicidal activity of 6g and 6h was better than the commercial pesticides amisulbrom and cyanosole